NCT01432262View on ClinicalTrials.gov

13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico

PHASE3CompletedINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

vaccine-13vPnC

Single dose of 0.5 ml of 13vPnC administered in deltoid muscle of arm at visit 1 (day 1)

BIOLOGICAL

vaccine-13vPnC

Single dose of 0.5 ml of 13vPnC administered in deltoid muscle of arm at visit 1 (day 1)

Trial Locations (4)

14000

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City

34000

Hospital General de Durango, Durango

06700

Instituto Mexicano de Investigación Clínica, S.A. de C.V, México

CP 58070

Star Medica, Morelia

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01432262 - 13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico | Biotech Hunter | Biotech Hunter